Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan E K Procter

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Heart Rhythm|December 23, 2015
New-onset atrial fibrillation and thromboembolic risk: Cardiovascular syzygy?Nathan E K Procter, Simon Stewart, John D Horowitz
ANZ Journal of Surgery|June 4, 2026
Clinically Significant Infections in Surgical MortalityEmily-Rose Lodge, Helena S Kopunic, Nathan E K Procter, et al.
The American Journal of Clinical Nutrition|February 5, 2020
Reply to TA Schiffer et alMaria Ntessalen, Nathan E K Procter, Martin Feelisch, et al.
ANZ Journal of Surgery|May 19, 2026
Changes in Surgical Admissions and Outcomes During and After the COVID-19 Pandemic: An Exploration of the Australian and New Zealand Audit of Surgical Mortality (ANZASM)Dharan A Shah, Nathan E K Procter, Helena S Kopunic, et al.
Seminars in Thrombosis and Hemostasis|September 1, 2014
Aging of platelet nitric oxide signaling: pathogenesis, clinical implications, and therapeuticsNathan E K Procter, Cher-Rin Chong, Aaron L Sverdlov, et al.
International Journal of Cardiology|August 21, 2013
Reciprocal regulation of NO signaling and TXNIP expression in humans: impact of aging and ramipril therapyAaron L Sverdlov, Wai P A Chan, Nathan E K Procter, et al.
Cardiovascular Drugs and Therapy|July 1, 2016
New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic ImplicationsNathan E K Procter, Nicola L Hurst, Vivek B Nooney, et al.
Herz|July 3, 2015
Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieuNathan E K Procter, Jocasta Ball, Doan T M Ngo, et al.
Heart and Vessels|August 29, 2019
Endothelial dysfunction and glycocalyx shedding in heart failure: insights from patients receiving cardiac resynchronisation therapyChukwudiebube N Ajaero, Nathan E K Procter, Yuliy Y Chirkov, et al.
Cardiovascular Drugs and Therapy|August 5, 2014
Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesCher-Rin Chong, Wai Ping A Chan, Thanh H Nguyen, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Heart Rhythm|December 23, 2015
New-onset atrial fibrillation and thromboembolic risk: Cardiovascular syzygy?Nathan E K Procter, Simon Stewart, John D Horowitz
ANZ Journal of Surgery|June 4, 2026
Clinically Significant Infections in Surgical MortalityEmily-Rose Lodge, Helena S Kopunic, Nathan E K Procter, et al.
The American Journal of Clinical Nutrition|February 5, 2020
Reply to TA Schiffer et alMaria Ntessalen, Nathan E K Procter, Martin Feelisch, et al.
ANZ Journal of Surgery|May 19, 2026
Changes in Surgical Admissions and Outcomes During and After the COVID-19 Pandemic: An Exploration of the Australian and New Zealand Audit of Surgical Mortality (ANZASM)Dharan A Shah, Nathan E K Procter, Helena S Kopunic, et al.
Seminars in Thrombosis and Hemostasis|September 1, 2014
Aging of platelet nitric oxide signaling: pathogenesis, clinical implications, and therapeuticsNathan E K Procter, Cher-Rin Chong, Aaron L Sverdlov, et al.
International Journal of Cardiology|August 21, 2013
Reciprocal regulation of NO signaling and TXNIP expression in humans: impact of aging and ramipril therapyAaron L Sverdlov, Wai P A Chan, Nathan E K Procter, et al.
Cardiovascular Drugs and Therapy|July 1, 2016
New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic ImplicationsNathan E K Procter, Nicola L Hurst, Vivek B Nooney, et al.
Herz|July 3, 2015
Platelet hyperaggregability in patients with atrial fibrillation. Evidence of a background proinflammatory milieuNathan E K Procter, Jocasta Ball, Doan T M Ngo, et al.
Heart and Vessels|August 29, 2019
Endothelial dysfunction and glycocalyx shedding in heart failure: insights from patients receiving cardiac resynchronisation therapyChukwudiebube N Ajaero, Nathan E K Procter, Yuliy Y Chirkov, et al.
Cardiovascular Drugs and Therapy|August 5, 2014
Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetesCher-Rin Chong, Wai Ping A Chan, Thanh H Nguyen, et al.
Pageof 2